These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 11793012)

  • 1. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.
    Bonora E; Muggeo M
    Diabetologia; 2001 Dec; 44(12):2107-14. PubMed ID: 11793012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
    Madsbad S; Brock B; Schmitz O
    Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of tissue damage in the postprandial state.
    Ceriello A
    Int J Clin Pract Suppl; 2001 Sep; (123):7-12. PubMed ID: 11594300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications.
    Qiao Q; Tuomilehto J; Borch-Johnsen K
    Diabetologia; 2003 Mar; 46 Suppl 1():M17-21. PubMed ID: 12652354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
    Karasik A
    Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.
    Ceriello A; Davidson J; Hanefeld M; Leiter L; Monnier L; Owens D; Tajima N; Tuomilehto J;
    Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):453-6. PubMed ID: 16934443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice.
    Boutati EI; Raptis SA
    Diabetes Metab Res Rev; 2004; 20 Suppl 2():S13-23. PubMed ID: 15551342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events.
    Gao W; Qiao Q; Tuomilehto J
    Clin Lab; 2004; 50(9-10):609-15. PubMed ID: 15481637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of postprandial hyperglycemia in cardiovascular disease.
    Fava S
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.
    Tushuizen ME; Diamant M; Heine RJ
    Postgrad Med J; 2005 Jan; 81(951):1-6. PubMed ID: 15640422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postprandial hyperglycemia and diabetic complications].
    Da Ros R; Assaloni R; Ceriello A
    Recenti Prog Med; 2005 Sep; 96(9):436-44. PubMed ID: 16229326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-prandial hyperglycaemia and vascular disease.
    Hanefeld M
    Int J Clin Pract Suppl; 2000 Sep; (112):13-8. PubMed ID: 11064946
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epidemiology of macroangiopathy in diabetes, including international comparisons].
    Nishimura R
    Nihon Rinsho; 2006 Nov; 64(11):2012-8. PubMed ID: 17087291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
    Bonora E
    Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
    Zeymer U
    Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia.
    Lee IK; Kim HS; Bae JH
    Int J Clin Pract Suppl; 2002 Jul; (129):59-64. PubMed ID: 12166609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary heart disease and insulin concentration in type II diabetic patients--results of a diabetes intervention study].
    Lindner J; Schmechel H; Hanefeld M; Schwanebeck U; Bauch K
    Z Gesamte Inn Med; 1992 Jun; 47(6):246-50. PubMed ID: 1642023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of postprandial hyperglycaemia on blood viscosity in aged patients suffering from type 2 diabetes as compared with healthy volunteers.
    Coppola L; Cerciello T; Boviatsi P; Pastore A; Coppola A; Antonio G; Mastrolorenzo L; Marfella R; Gombos G
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):745-50. PubMed ID: 17982315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease.
    Peter R; Okosieme OE; Evans LM
    Expert Opin Pharmacother; 2010 Jan; 11(1):33-9. PubMed ID: 20001427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point.
    Haffner S
    Int J Clin Pract Suppl; 2001 Sep; (123):24-6. PubMed ID: 11594293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.